Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2Phase 4 1Phase 3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma 22Breast Neoplasms 16Leukemia 13Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Hodgkin Disease 11Neuroblastoma 10Lymphoma, Follicular 10Burkitt Lymphoma 10Leukemia, Myeloid, Acute 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neutropenia 8Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Acute 8Leukemia, Monocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Neoplasms, Plasma Cell 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Malignant mesenchymal tumor 5Congenital Abnormalities 5Rhabdomyosarcoma 4Leukemia, Myeloid, Chronic-Phase 4Kidney Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4Endometrial Neoplasms 4Central Nervous System Neoplasms 4Carcinoma, Non-Small-Cell Lung 4

Interventions

Tretinoin 12Arsenic Trioxide 7Methotrexate 5Mercaptopurine 5Cytarabine 5Idarubicin 4Mitoxantrone 3Thioguanine 2Radiotherapy 2Etoposide 2Daunorubicin 2Cyclophosphamide 2sargramostim 1merphos 1flt3 ligand protein 1Peripheral Blood Stem Cell Transplantation 1Maintenance 1Hydroxyurea 1Filgrastim 1Busulfan 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Promyelocytic, Acute × Filgrastim × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡